Deregulation and therapeutic potential of microRNAs in arthritic diseases

Nature Reviews Rheumatology

Volumn 12, Issue 4, 2016, Pages 211-220

  Vicente, Rita ^a   Noël, Danièle ^a   Pers, Yves Marie ^b   Apparailly, Florence ^a   Jorgensen, Christian ^b  

^a HÔPITAL SAINT ELOI   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATELOCOLLAGEN; METHOTREXATE; MICRORNA; MICRORNA 145; MICRORNA 146A; MICRORNA 15A; MICRORNA 210; MICRORNA 26A; RETINOIC ACID INDUCIBLE PROTEIN I;

ARTHRITIS; BONE CELL; BONE REMODELING; CELL FATE; CELL LINE; CELL PROLIFERATION; CYTOKINE RELEASE; EPIGENETICS; EXTRACELLULAR MATRIX; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; MESENCHYMAL STROMA CELL; MUSCLE CELL; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; BONE MARROW CELL; CELL DIFFERENTIATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING;

ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; HUMANS; IMMUNE TOLERANCE; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYELOID CELLS; OSTEOARTHRITIS; TISSUE ENGINEERING;

EID: 84951335054     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2015.162     Document Type: Review

References (136)

1. Chang, T. C. & Mendell, J. T. MicroRNAs in vertebrate physiology and human disease. Annu. Rev. Genom. Hum. Genet. 8, 215-239 (2007).
2. Ghildiyal, M. & Zamore, P. D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10, 94-108 (2009).
3. Hausser, J. & Zavolan, M. Identification and consequences of miRNA-target interactions - beyond repression of gene expression. Nat. Rev. Genet. 15, 599-612 (2014).
4. Jia, S., Zhai, H. & Zhao, M. MicroRNAs regulate immune system via multiple targets. Discov. Med. 18, 237-247 (2014).
5. Salama, A. et al. MicroRNA 29b modulates innate and antigen specific immune responses in mouse models of autoimmunity. PLoS ONE 9, e106153 (2014).
6. Shen, N., Liang, D., Tang, Y., de Vries, N. & Tak, P. P. MicroRNAs - novel regulators of systemic lupus erythematosus pathogenesis. Nat. Rev. Rheumatol. 8, 701-709 (2012).
7. Frangou, E. A., Bertsias, G. K. & Boumpas, D. T. Gene expression and regulation in systemic lupus erythematosus. Eur. J. Clin. Invest. 43, 1084-1096 (2013).
8. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006).
9. Clark, E. A., Kalomoiris, S., Nolta, J. A. & Fierro, F. A. Concise review: microRNA function in multipotent mesenchymal stromal cells. Stem Cells 32, 1074-1082 (2014).
10. Lakshmipathy, U. & Hart, R. P. Concise review: microRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26, 356-363 (2008).
11. Huang, J., Zhao, L., Xing, L. & Chen, D. MicroRNA 204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 28, 357-364 (2010).
12. Hamam, D. et al. MicroRNA 320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells. Cell Death Dis. 5, e1499 (2014).
13. Zaragosi, L. E. et al. Small RNA sequencing reveals miR 642a 3p as a novel adipocyte specific microRNA and miR 30 as a key regulator of human adipogenesis. Genome Biol. 12, R64 (2011).
14. Zhang, J. F. et al. miR 637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol. Biol. Cell 22, 3955-3961 (2011).
15. Tomé, M. et al. miR 335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 18, 985-995 (2011).
16. Eskildsen, T. et al. MicroRNA 138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc. Natl Acad. Sci. USA 108, 6139-6144 (2011).
17. Gibson, G. & Asahara, H. MicroRNAs and cartilage. J. Orthop. Res. 31, 1333-1344 (2013).
18. Jia, J. et al. miR 145 suppresses osteogenic differentiation by targeting Sp7. FEBS Lett. 587, 3027-3031 (2013).
19. Li, E., Zhang, J., Yuan, T. & Ma, B. miR 143 suppresses osteogenic differentiation by targeting Osterix. Mol. Cell Biochem. 390, 69-74 (2014).
20. Guérit, D. et al. FOXO3A regulation by miRNA 29a controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation. Stem Cells Dev. 23, 1195-1205 (2014).
21. Umeda, M., Terao, F., Miyazaki, K., Yoshizaki, K. & Takahashi, I. MicroRNA 200a regulates the development of mandibular condylar cartilage. J. Dent. Res. 94, 795-802 (2015).
22. Kapinas, K., Kessler, C., Ricks, T., Gronowicz, G. & Delany, A. M. miR 29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 285, 25221-25231 (2010).
23. Karbiener, M. et al. MicroRNA miR 27b impairs human adipocyte differentiation and targets PPARγ. Biochem. Biophys. Res. Commun. 390, 247-251 (2009).
24. Kim, S. Y. et al. miR 27a is a negative regulator of adipocyte differentiation via suppressing PPARγ expression. Biochem. Biophys. Res. Commun. 392, 323-328 (2010).
25. Lee, E. K. et al. miR 130 suppresses adipogenesis by inhibiting peroxisome proliferator activated receptor γ expression. Mol. Cell. Biol. 31, 626-638 (2011).
26. Hamam, D., Ali, D., Kassem, M., Aldahmash, A. & Alajez, N. M. MicroRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev. 24, 417-425 (2015).
27. Ahn, J., Lee, H., Jung, C. H., Jeon, T. I. & Ha, T. Y. MicroRNA 146b promotes adipogenesis by suppressing the SIRT1-FOXO1 cascade. EMBO Mol. Med. 5, 1602-1612 (2013).
28. Kim, Y. J., Bae, S. W., Yu, S. S., Bae, Y. C. & Jung, J. S. miR 196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J. Bone Miner. Res. 24, 816-825 (2009).
29. Mizuno, Y. et al. miR 210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 583, 2263-2268 (2009).
30. Li, H. et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest. 119, 3666-3677 (2009).
31. Kim, D. et al. Two non coding RNAs, microRNA 101 and HOTTIP contribute cartilage integrity by epigenetic and homeotic regulation of integrin α1. Cell Signal 25, 2878-2887 (2013).
32. Kim, M., Kim, C., Choi, Y. S., Park, C. & Suh, Y. Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age associated bone diseases and defects. Mech. Ageing Dev. 133, 215-225 (2012).
33. Martinez-Sanchez, A., Dudek, K. A. & Murphy, C. L. Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA 145 (miRNA 145). J. Biol. Chem. 287, 916-924 (2012).
34. Xu, J., Kang, Y., Liao, W. M. & Yu, L. miR 194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5. PLoS ONE 7, e31861 (2012).
35. Lin, E. A., Kong, L., Bai, X. H., Luan, Y. & Liu, C. J. miR 199a, a bone morphogenic protein 2 responsive microRNA, regulates chondrogenesis via direct targeting to Smad1. J. Biol. Chem. 284, 11326-11335 (2009).
36. Guirit, D. et al. Sox9 regulated miRNA 574 3p inhibits chondrogenic differentiation of mesenchymal stem cells. PLoS ONE 8, e62582 (2013).
37. Ham, O. et al. The role of microRNA 23b in the differentiation of MSC into chondrocyte by targeting protein kinase A signaling. Biomaterials 33, 4500-4507 (2012).
38. Tuddenham, L. et al. The cartilage specific microRNA 140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 580, 4214-4217 (2006).
39. Djouad, F. et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837-3844 (2003).
40. Marigo, I. & Dazzi, F. The immunomodulatory properties of mesenchymal stem cells. Semin. Immunopathol. 33, 593-602 (2011).
41. Le Blanc, K. & Mougiakakos, D. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 12, 383-396 (2012).
42. Liu, L. et al. MicroRNA 181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells. Stem Cells 30, 1756-1770 (2012).
43. Xu, C. et al. miR 155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1 binding protein 2. J. Biol. Chem. 288, 11074-11079 (2013).
44. Zhao, X. et al. The toll like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting miR 143. Stem Cells 32, 521-533 (2014).
45. Chen, K. D. et al. Identification of miR 27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response. PLoS ONE 8, e60492 (2013).
46. Matysiak, M. et al. MicroRNA 146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase 2. J. Immunol. 190, 5102-5109 (2013).
47. Jones, S. W. et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-α and MMP13. Osteoarthr. Cartil. 17, 464-472 (2009).
48. Iliopoulos, D., Malizos, K. N., Oikonomou, P. & Tsezou, A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE 3, e3740 (2008).
49. Tardif, G., Hum, D., Pelletier, J. P., Duval, N. & Martel Pelletier, J. Regulation of the IGFBP 5 and MMP 13 genes by the microRNAs miR 140 and miR 27a in human osteoarthritic chondrocytes. BMC Musculoskelet. Disord. 10, 148 (2009).
50. Miyaki, S. et al. MicroRNA 140 is expressed in differentiated human articular chondrocytes and modulates interleukin 1 responses. Arthritis Rheum. 60, 2723-2730 (2009).
51. Miyaki, S. et al. MicroRNA 140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 24, 1173-1185 (2010).
52. Nakamura, Y. et al. Sox9 is upstream of microRNA 140 in cartilage. Appl. Biochem. Biotechnol. 166, 64-71 (2012).
53. Akhtar, N. et al. MicroRNA 27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 62, 1361-1371 (2010).
54. Mirzamohammadi, F., Papaioannou, G. & Kobayashi, T. MicroRNAs in cartilage development, homeostasis, and disease. Curr. Osteoporos Rep. 12, 410-419 (2014).
55. Swingler, T. E. et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum. 64, 1909-1919 (2012).
56. Ham, O. et al. Upregulation of miR 23b enhances the autologous therapeutic potential for degenerative arthritis by targeting PRKACB in synovial fluid derived mesenchymal stem cells from patients. Mol. Cells 37, 449-456 (2014).
57. Yamasaki, K. et al. Expression of MicroRNA 146a in osteoarthritis cartilage. Arthritis Rheum. 60, 1035-1041 (2009).
58. Gu, S. X. et al. MicroRNA 146a reduces IL 1 dependent inflammatory responses in the intervertebral disc. Gene 555, 80-87 (2015).
59. Yang, B. et al. Effect of microRNA 145 on IL 1β induced cartilage degradation in human chondrocytes. FEBS Lett. 588, 2344-2352 (2014).
60. Akhtar, N. & Haqqi, T. M. MicroRNA 199a∗ regulates the expression of cyclooxygenase 2 in human chondrocytes. Ann. Rheum. Dis. 71, 1073-1080 (2012).
61. Park, S. J., Cheon, E. J. & Kim, H. A. MicroRNA 558 regulates the expression of cyclooxygenase 2 and IL 1β induced catabolic effects in human articular chondrocytes. Osteoarthr. Cartil. 21, 981-989 (2013).
62. Li, X. et al. Altered spinal microRNA 146a and the microRNA 183 cluster contribute to osteoarthritic pain in knee joints. J. Bone Miner. Res. 28, 2512-2522 (2013).
63. Santini, P., Politi, L., Vedova, P. D., Scandurra, R. & Scotto d'Abusco, A. The inflammatory circuitry of miR 149 as a pathological mechanism in osteoarthritis. Rheumatol. Int. 34, 711-716 (2014).
64. Djouad, F. et al. Transcriptional profiles discriminate bone marrow derived and synovium derived mesenchymal stem cells. Arthritis Res. Ther. 7, R1304-R1315 (2005).
65. Klein, K., Ospelt, C. & Gay, S. Epigenetic contributions in the development of rheumatoid arthritis. Arthritis Res. Ther. 14, 227 (2012).
66. Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S. & Neidhart, M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 60, 3613-3622 (2009).
67. Bottini, N. & Firestein, G. S. Duality of fibroblast like synoviocytes in RA: passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9, 24-33 (2013).
68. Nakasa, T. et al. Expression of microRNA 146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 58, 1284-1292 (2008).
69. Stanczyk, J. et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58, 1001-1009 (2008).
70. Long, L. et al. Upregulated microRNA 155 expression in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis. Clin. Dev. Immunol. 2013, 296139 (2013).
71. O'Connell, R. M. et al. MicroRNA 155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619 (2010).
72. Kurowska Stolarska, M. et al. MicroRNA 155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl Acad. Sci. USA 108, 11193-11198 (2011).
73. Blüml, S. et al. Essential role of microRNA 155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum. 63, 1281-1288 (2011).
74. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF κB-dependent induction of microRNA miR 146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481-12486 (2006).
75. Stanczyk, J. et al. Altered expression of microRNA 203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 63, 373-381 (2011).
76. Pandis, I. et al. Identification of microRNA 221/222 and microRNA 323 3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann. Rheum. Dis. 71, 1716-1723 (2012).
77. Wang, S. et al. Upregulation of microRNA 203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer. Med. Oncol. 30, 681 (2013).
78. Chang, X. et al. miR 203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1. Biochem. Biophys. Res. Commun. 456, 361-366 (2015).
79. Wong, Q. W. et al. miR 222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin. Cancer Res. 16, 867-875 (2010).
80. Shah, M. Y. & Calin, G. A. MicroRNAs miR 221 and miR 222: a new level of regulation in aggressive breast cancer. Genome Med. 3, 56 (2011).
81. Yang, S. & Yang, Y. Downregulation of microRNA 221 decreases migration and invasion in fibroblast like synoviocytes in rheumatoid arthritis. Mol. Med. Rep. 12, 2395-2401 (2015).
82. Lin, J. et al. A novel p53/microRNA 22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol. 66, 49-59 (2014).
83. Zhang, Q. et al. A critical role of Cyr61 in interleukin-17 dependent proliferation of fibroblast like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 60, 3602-3612 (2009).
84. Niederer, F. et al. Down regulation of microRNA 34a∗ in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis Rheum. 64, 1771-1779 (2012).
85. Nakamachi, Y. et al. MicroRNA 124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 60, 1294-1304 (2009).
86. Zhou, Q. et al. Research of the methylation status of miR 124a gene promoter among rheumatoid arthritis patients. Clin. Dev. Immunol. 2013, 524204 (2013).
87. Miao, C. G. et al. MicroRNA 152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model. Biochimie 106, 149-156 (2014).
88. Miao, C. G. et al. miR 375 regulates the canonical Wnt pathway through FZD8 silencing in arthritis synovial fibroblasts. Immunol. Lett. 164, 1-10 (2015).
89. Philippe, L., Alsaleh, G., Bahram, S., Pfeffer, S. & Georgel, P. The miR 17 ∼ 92 cluster: a key player in the control of inflammation during rheumatoid arthritis. Front. Immunol. 4, 70 (2013).
90. Trenkmann, M. et al. Tumor necrosis factor α induced microRNA 18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF κB signaling. Arthritis Rheum. 65, 916-927 (2013).
91. Philippe, L. et al. TLR2 expression is regulated by microRNA miR 19 in rheumatoid fibroblast like synoviocytes. J. Immunol. 188, 454-461 (2012).
92. Philippe, L. et al. miR 20a regulates ASK1 expression and TLR4 dependent cytokine release in rheumatoid fibroblast like synoviocytes. Ann. Rheum. Dis. 72, 1071-1079 (2013).
93. Alsaleh, G. et al. miR 30a 3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts. PLoS ONE 9, e111266 (2014).
94. Niimoto, T. et al. MicroRNA 146a expresses in interleukin 17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet. Disord. 11, 209 (2010).
95. Li, J. et al. Altered microRNA expression profile with miR 146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res. Ther. 12, R81 (2010).
96. Pauley, K. M. et al. Upregulated miR 146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 10, R101 (2008).
97. Nakasa, T., Shibuya, H., Nagata, Y., Niimoto, T. & Ochi, M. The inhibitory effect of microRNA 146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 63, 1582-1590 (2011).
98. Chen, T. et al. MicroRNA 146a regulates the maturation process and pro inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett. 585, 567-573 (2011).
99. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D. MicroRNA 155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104, 1604-1609 (2007).
100. Mann, M., Barad, O., Agami, R., Geiger, B. & Hornstein, E. miRNA based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc. Natl Acad. Sci. USA 107, 15804-15809 (2010).
101. Rodriguez, A. et al. Requirement of bic/microRNA 155 for normal immune function. Science 316, 608-611 (2007).
102. Thai, T. H. et al. Regulation of the germinal center response by microRNA 155. Science 316, 604-608 (2007).
103. Teng, G. et al. MicroRNA 155 is a negative regulator of activation induced cytidine deaminase. Immunity 28, 621-629 (2008).
104. Smigielska Czepiel, K. et al. Comprehensive analysis of miRNA expression in T cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun. 15, 115-125 (2014).
105. Zhou, Q. et al. Decreased expression of miR 146a and miR 155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis. Ann. Rheum. Dis. 74, 1265-1274 (2015).
106. Boldin, M. P. et al. miR 146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201 (2011).
107. Starczynowski, D. T. et al. Identification of miR 145 and miR 146a as mediators of the 5q syndrome phenotype. Nat. Med. 16, 49-58 (2010).
108. Guo, Q. et al. Forced miR 146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells. Blood 121, 4875-4883 (2013).
109. Lochhead, R. B. et al. MicroRNA 146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi. PLoS Pathog. 10, e1004212 (2014).
110. Schulte, L. N., Westermann, A. J. & Vogel, J. Differential activation and functional specialization of miR 146 and miR 155 in innate immune sensing. Nucleic Acids Res. 41, 542-553 (2013).
111. Zhao, J. L., Rao, D. S., O'Connell, R. M., Garcia Flores, Y. & Baltimore, D. MicroRNA 146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice. eLIFE 2, e00537 (2013).
112. Rouas, R. et al. Human natural Treg microRNA signature: role of microRNA 31 and microRNA 21 in FOXP3 expression. Eur. J. Immunol. 39, 1608-1618 (2009).
113. Sawant, D. V., Wu, H., Kaplan, M. H. & Dent, A. L. The Bcl6 target gene microRNA 21 promotes Th2 differentiation by a T cell intrinsic pathway. Mol. Immunol. 54, 435-442 (2013).
114. Dong, L. et al. Decreased expression of microRNA 21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J. Cell. Mol. Med. 18, 2213-2224 (2014).
115. van der Geest, K. S. et al. SF Treg cells transcribing high levels of Bcl 2 and microRNA 21 demonstrate limited apoptosis in RA. Rheumatology (Oxford) 54, 950-958 (2015).
116. Lu, M. C. et al. Increased miR 223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin like growth factor 1 mediated interleukin 10 production. Clin. Exp. Immunol. 177, 641-651 (2014).
117. Fulci, V. et al. miR 223 is overexpressed in T lymphocytes of patients affected by rheumatoid arthritis. Hum. Immunol. 71, 206-211 (2010).
118. Li, Y. T. et al. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA 223. Arthritis Rheum. 64, 3240-3245 (2012).
119. Sugatani, T., Vacher, J. & Hruska, K. A. A microRNA expression signature of osteoclastogenesis. Blood 117, 3648-3657 (2011).
120. Haftmann, C. et al. miR 148a is upregulated by Twist1 and T bet and promotes Th1 cell survival by regulating the proapoptotic gene Bim. Eur. J. Immunol. 45, 1192-1205 (2015).
121. Murata, K. et al. MicroRNA 451 down regulates neutrophil chemotaxis via p38 MAPK. Arthritis Rheumatol. 66, 549-559 (2014).
122. Jiang, C. et al. MicroRNA 26a negatively regulates toll like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. Arthritis Res. Ther. 16, R9 (2014).
123. Vinatier, C. et al. Cartilage tissue engineering: towards a biomaterial assisted mesenchymal stem cell therapy. Curr. Stem Cell Res. Ther. 4, 318-329 (2009).
124. Ochi, M., Nakasa, T., Kamei, G., Usman, M. A. & El Mahmoud, H. Regenerative medicine in orthopedics using cells, scaffold, and microRNA. J. Orthop. Sci. 19, 521-528 (2014).
125. Li, Y. et al. The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA 26a. Biomaterials 34, 5048-5058 (2013).
126. Shoji, T. et al. The effect of intra articular injection of microRNA 210 on ligament healing in a rat model. Am. J. Sports Med. 40, 2470-2478 (2012).
127. Karlsen, T. A. & Brinchmann, J. E. Liposome delivery of microRNA 145 to mesenchymal stem cells leads to immunological off target effects mediated by RIG I. Mol. Ther. 21, 1169-1181 (2013).
128. Apparailly, F. & Jorgensen, C. siRNA based therapeutic approaches for rheumatic diseases. Nat. Rev. Rheumatol. 9, 56-62 (2013).
129. Nakamachi, Y. et al. MicroRNA 124 inhibits the progression of adjuvant induced arthritis in rats. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2014-206417 (2015).
130. Lee, Y. et al. MicroRNA 124 regulates osteoclast differentiation. Bone 56, 383-389 (2013).
131. Nagata, Y. et al. Induction of apoptosis in the synovium of mice with autoantibody mediated arthritis by the intraarticular injection of double stranded microRNA 15a. Arthritis Rheum. 60, 2677-2683 (2009).
132. Leah, E. Rheumatoid arthritis: miR 155 mediates inflammation. Nat. Rev. Rheumatol. 7, 437 (2011).
133. Duroux Richard, I., Jorgensen, C. & Apparailly, F. What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum. 64, 11-20 (2012).
134. Duroux Richard, I., Jorgensen, C. & Apparailly, F. miRNAs and rheumatoid arthritis - promising novel biomarkers. Swiss Med. Wkly 141, w13175 (2011).
135. Alevizos, I. & Illei, G. G. MicroRNAs as biomarkers in rheumatic diseases. Nat. Rev. Rheumatol. 6, 391-398 (2010).
136. Beyer, C. et al. Signature of circulating microRNAs in osteoarthritis. Ann. Rheum. Dis. 74, e18 (2015).